Fecal transplant to treat irritable bowel syndrome

This trial tests if a fecal microbiota transplant (FMT) can help young adults with irritable bowel syndrome with diarrhea (IBS-D) who also have symptoms of anxiety or depression. FMT involves putting processed stool from a healthy donor into your gut to improve digestive and mental health at the same time.

This trial studies fecal microbiota transplantation (a stool-based treatment) to improve symptoms and safety in people with certain gut and immune conditions. It aims to see whether changing gut bacteria can help you feel better.

This trial tests whether transplanting stool bacteria into the colon (fecal microbiota transplantation) can improve ulcerative colitis symptoms in people with active, moderate to severe disease. If you qualify, the study team will also check that it’s safe for you and that you can safely undergo a scope exam.

This trial studies whether fecal microbiota transplantation (FMT)—a medical procedure using stool from a screened donor to restore gut bacteria—can improve safety and outcomes for people with certain bowel, immune, and metabolic conditions. It may help if your symptoms are thought to be related to an unhealthy gut microbiome, though eligibility is broad and depends on specific safety factors.

This trial studies fecal microbiota transplantation, which is transferring stool bacteria from a healthy donor to help rebalance gut microbes. If you have irritable bowel syndrome (IBS) that hasn’t improved after several standard treatments, this study may see whether it reduces your symptoms and is safe.

This study tests whether a fecal microbiota transplant (FMT) — transferring healthy stool bacteria into your gut — can help people with severe irritable bowel syndrome (IBS) that hasn't improved after trying at least two other treatments.